Compare Indonesia Energy Corporation Limited (INDO) vs Inovio Pharmaceuticals Inc (INO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Indonesia Energy Corporation Limited vs Inovio Pharmaceuticals Inc — how do they compare? Indonesia Energy Corporation Limited trades at $2.92 (market cap $45.55M), while Inovio Pharmaceuticals Inc trades at $0.77 (market cap $78.55M). The key difference: Inovio Pharmaceuticals Inc is the larger of the two by market cap. Which is the better fit depends on your goals.
| INDO | INO | |
|---|---|---|
Market Cap | $45.55M | $78.55M |
Sector | Energy | Health |
52-Week High | $6.74 | $2.87 |
52-Week Low | $2.49 | $0.66 |
Enterprise Value | $40.92M | $49.56M |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
INDO trades at $2.97, up 1.71% today, with a bullish technical signal supported by moving averages. The company reported a net loss of $5 million on $2 million revenue in 2025, resulting in negative profit margins. Recent news highlights operational progress with the commencement of drilling at the K-29 well in Indonesia. Analyst consensus is unanimously bullish with three buy ratings.
The outlook hinges on successful well development driving future revenue growth, but high valuation multiples and persistent losses pose significant risks. Investors face volatility from execution challenges in oil and gas exploration, though positive analyst sentiment suggests potential upside if operational milestones are met.
INO trades at $0.772, up 4.83% in the last 24 hours, but technical indicators signal a bearish trend. The company shows minimal revenue of $65,340 in 2025 with a net loss of $84.95 million, though it has beaten EPS estimates in recent quarters. Key developments include an upcoming Q2 2026 earnings report on August 12, 2026, and a pending FDA decision on INO-3107 by October 30, 2026.
The outlook hinges on FDA approval of INO-3107, with a consensus price target of $3.25 implying significant upside. However, high cash burn, negative margins, and legal scrutiny pose substantial risks. Investors should weigh the binary event against persistent financial challenges.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Indonesia Energy Corporation Limited
Indonesia Energy is an oil and gas exploration and production company. It focuses on identifying and developing energy resources in Indonesia, primarily through its Kruh and Citarum blocks.
Read more on INDO →About Inovio Pharmaceuticals Inc
Inovio Pharmaceuticals Inc is a United States based biotechnology company that develops active DNA-based immunotherapies and vaccines to treat and prevent cancers and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.
Read more on INO →
